Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP block versus intravenous lidocaine for pain management after video-assisted thoracic surgery
ACTRN12621001609842Phase 2Not yet recruiting
- Sponsor
- South Metropolitan Health Service
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of lidocaine and ropivacaine in postoperative pain (2 arms), sponsored by South Metropolitan Health Service. Primary endpoints: Amount of fentanyl used in PCA in first 24 hours, Serum lidocaine concentration and 1 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
lidocaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12621001609842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001609842.